Patients may need a more careful discussion if they have a history of: Previous NAION in one eye Significant optic nerve crowding Diabetes with vascular complications Sleep apnea, especially untreated sleep apnea High blood pressure or low nighttime blood pressure Cardiovascular disease Sudden unexplained vision loss in the past This does not automatically mean a GLP-1 medication is unsafe, but it does mean the patient should have a personalized risk-benefit discussion with their medical provider
More research is needed to fully understand its efficacy for weight loss in adults experiencing mental illness
By stimulating the testes directly, it helps maintain their function during the transition period while the pituitary slowly resumes normal LH production
Clinical trials show tirzepatide produces up to 15% body weight reduction compared to semaglutide's typical 10-12%, with superior A1C reductions averaging 2.0-2.3% versus 1.5-1.8%
Medication costs vary from treatment to treatment but will be in line with what you would pay at a pharmacy in person
Wegovy and Semaglutide are often discussed interchangeably, but they represent different aspects of the same medication
